System theoretical investigation of human epidermal growth factor receptor-mediated signalling

IET Systems Biology

Volumn 2, Issue 5, 2008, Pages 273-284

  Zhang, Y ^a   Shankaran, H ^a   Opresko, L ^a   Resat, Haluk ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; BIOLOGICAL SYSTEMS; CELL CULTURE; CELL GROWTH; ELECTRIC NETWORK ANALYSIS; NETWORK PROTOCOLS; PEPTIDES; SENSOR NETWORKS; TRANSFER FUNCTIONS;

BIOLOGICAL NETWORKS; CELL LINES; CONTROLLED PERTURBATIONS; ENDOGENOUS LEVELS; EPIDERMAL GROWTH FACTOR RECEPTORS; EXPERIMENTAL DATUM; FUNCTIONAL MODULES; HUMAN EPIDERMAL GROWTH FACTORS; INFORMATION TRANSFERS; INTERNAL DYNAMICS; MEDIATED SIGNALLING; NETWORK MODULES; OUTPUT CHARACTERISTICS; PREDICTIVE MODELS; QUANTITATIVE; SIGNALLING PATHWAYS; SYSTEM DYNAMICS; SYSTEMATIC ANALYSIS; THEORETICAL ANALYSES;

DYNAMICS;

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

CELL LINE; CONFERENCE PAPER; ENZYME ACTIVATION; GENE REGULATORY NETWORK; GENETIC MODEL; HUMAN; HUMAN CELL; INFORMATION PROCESSING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SYSTEM ANALYSIS; THEORETICAL STUDY;

CELL LINE; COMPUTER SIMULATION; EPITHELIAL CELLS; HUMANS; MODELS, BIOLOGICAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 54049149007     PISSN: 17518849     EISSN: None     Source Type: Journal    
DOI: 10.1049/iet-syb:20080116     Document Type: Conference Paper

References (52)

1. Csete, M.E., and Doyle, J.C.: 'Reverse engineering of biological complexity', Science, 2002, 295, p. 1664-1669 0036-8075
2. Hartwell, L.H., Hopfield, J.J., Leibler, S., and Murray, A.W.: 'From molecular to modular cell biology', Nature, 1999, 402, p. C47-C52 0028-0836
3. Lauffenburger, D.A.: 'Cell signaling pathways as control modules: complexity for simplicity?', Proc., Natl. Acad. Sci. USA, 2000, 97, p. 5031-5033 0027-8424
4. Kumar, N., Wolf-Yadlin, A., White, F.M., and Lauffenburger, D.A.: 'Modeling HER2 effects on cell behavior from mass spectrometry phosphotyrosine data', PLoS Comput. Biol., 2007, 3, p. e4
5. Hendriks, B.S., Orr, G., Wells, A., Wiley, H.S., and Lauffenburger, D.A.: 'Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells', J. Biol. Chem., 2005, 280, p. 6157-6169
6. Bruggeman, F.J., Westerhoff, H.V., Hoek, J.B., and Kholodenko, B.N.: 'Modular response analysis of cellular regulatory networks', J. Theor. Biol., 2002, 218, p. 507-520
7. Krakauer, D.C., Page, K.M., and Sealfon, S.: 'Module dynamics of the GnRH signal transduction network', J. Theor. Biol., 2002, 218, p. 457-470
8. Saez-Rodriguez, J., Kremling, A., Conzelmann, H., Bettenbrock, K., and Gilles, E.D.: 'Modular analysis of signal transduction networks', IEEE Control Syst. Mag., 2004, 24, p. 35-52 0272-1708
9. Snoep, J.L., Bruggeman, F., Olivier, B.G., and Westerhoff, H.V.: 'Towards building the silicon cell: A modular approach', Biosystems, 2006, 83, p. 207-216
10. Sontag, E.D.: 'Some new directions in control theory inspired by systems biology', Syst. Biol. (Stevenage), 2004, 1, p. 9-18
11. van Riel, N.A., and Sontag, E.D.: 'Parameter estimation in models combining signal transduction and metabolic pathways: The dependent input approach', Syst. Biol. (Stevenage), 2006, 153, p. 263-274
12. Chaves, M., Sontag, E.D., and Dinerstein, R.: 'Optimal length and signal amplification in weakly activated signal transduction', J. Phys. Chem. B, 2004, 108, p. 15311-15320 1089-5647
13. Conzelmann, H., Saez-Rodriguez, J., Sauter, T., Bullinger, E., Allgower, F., and Gilles, E.D.: 'Reduction of mathematical models of signal transduction networks: Simulation-based approach applied to EGF receptor signalling', Syst. Biol. (Stevenage), 2004, 1, p. 159-169
14. Schmidt, H., and Jacobsen, E.W.: 'Linear systems approach to analysis of complex dynamic behaviours in biochemical networks', Syst. Biol. (Stevenage), 2004, 1, p. 149-158
15. Downward, J., Yarden, Y., and Mayes, E.: Et al. 'Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences', Nature, 1984, 307, p. 521-527 0028-0836
16. Prenzel, N., Zwick, E., Leserer, M., and Ullrich, A.: 'Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification', Breast Cancer Res., 2000, 2, p. 184-190
17. Jorissen, R.N., Walker, F., Pouliot, N., Garrett, T.P., Ward, C.W., and Burgess, A.W.: 'Epidermal groMth factor receptor: mechanisms of activation and signalling', Exp. Cell. Res., 2003, 284, p. 31-53
18. Stern, D.F.: 'ErbBs in mammary development', Exp. Cell. Res., 2003, 284, p. 89-98
19. Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A., and McGuire, W.L.: 'Cuman breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene', Science, 1987, 235, p. 177-182 0036-8075
20. Schlessinger, J.: 'Cell signaling by receptor tyrosine kinases', Cell., 2000, 103, p. 211-225
21. Citri, A., and YTrden, Y.: 'EGF-ERBB signalling: towards the systems level', Nat. Rev. Mol. Cell Biol., 2006, 7, p. 505-516
22. Mass R.D. 'The HER receptor family: A rich target for therapeutic development', Int. J. Radiat. Oncol. Biol. Phys., 2004, 58, p. 932-940
23. Shankaran, H., Wiley, H.S., and Resat, H.: 'Modeling the effects of HER/ ErbB1-3 coexpression on receptor dimerization and biological response', Biophys. J., 2006, 90, p. 3993-4009 10.1529/biophysj.105.080580 0006-3495
24. Wiley, H.S.: 'Trafficking of the ErbB receptors and its influence on signaling', Exp. Cell Res., 2003, 284, p. 78-88
25. Tzahar, E., Waterman, H., and Chen, X.M.: Et al. 'A hierarchical network of interreceptor interactions determines signal transduction by neu differentiation factor/neuregulin and epidermal growth factor', Mol. Cell. Biol., 1996, 16, p. 5276-5287
26. Olayioye, M.A., Neve, R.M., Lane, H.A., and Hynes, N.E.: 'The ErbB signaling network: Receptor heterodimerization in development and cancer', Embo J., 2000, 19, p. 3159-3167
27. Pinkas-Kramarski, R., Soussan, L., and Waterman, H.: Et al. 'Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions', Embo J., 1996, 15, p. 2452-2467
28. Yen, L., Benlimame, N., and Nie, Z.R.: Et al. 'Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers', Mol. Biol. Cell., 2002, 13, p. 4029-4044
29. Holbro, T., Civenni, G., and Hynes, N.E.: 'The ErbB receptors and their role in cancer progression', Exp. Cell. Res., 2003, 284, p. 99-110
30. Olayioye, M.A., Graus-Porta, D., Beerli, R.R., Rohrer, J., Gay, B., and Hynes, N.E.: 'ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner', Mol. Cell. Biol., 1998, 18, p. 5042-5051
31. Hung, M.C., and Lau, Y.A.: 'Basic science of HER-2/neu: a review', Semin. Oncol., 1999, 26, p. 51-59
32. Reese, D.M., and Slamon, D.J.: 'HER-2/neu signal transduction in human breast and ovarian cancer', Stem Cells, 1997, 15, p. 1-8
33. Yarden, Y., and Sliwkowski, M.X.: 'Untangling the ErbB signalling network', Nat. Rev. Mol. Cell. Biol., 2001, 2, p. 127-137
34. Birtwistle, M.R., Hatakeyama, M., Yumoto, N., Ogunnaike, B.A., Hoek, J.B., and Kholodenko, B.N.: 'Ligand-dependent responses of the ErbB signaling network: Experimental and modeling analyses', Mol. Syst. Biol., 2007, 3, p. 144
35. Mansour, S.J., Candia, J.M., Gloor, K.K., and Ahn, N.G.: 'Constitutively active mitogen-activated protein kinase kinase 1 (MAPKK1) and MAPKK2 mediate similar transcriptional and morphological responses', Cell Growth Differ., 1996, 7, p. 243-250
36. Robinson, M.J., Stippec, S.A., Goldsmith, E., White, M.A., and Cobb, M.H.: 'A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation', Curr. Biol., 1998, 8, p. 1141-1150
37. Cowley, S., Paterson, H., Kemp, P., and Marshall, C.J.: 'Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells', Cell, 1994, 77, p. 841-852
38. Kamata, H., Tanaka, C., and Yagisawa, H.: Et al. 'Suppression of nerve growth factor-induced neuronal differentiation of PC12 cells. N-acetylcysteine uncouples the signal transduction from ras to the mitogen-activated protein kinase cascade', J. Biol. Chem., 1996, 271, p. 33018-33025
39. Marshall, C.J.: 'Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation', Cell, 1995, 80, p. 179-185
40. Ahmed, K.M., Cao, N., and Li, J.J.: 'HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer', Anticancer Res., 2006, 26, p. 4235-4243
41. Song, G., Ouyang, G., and Bao, S.: 'The activation of Akt/PKB signaling pathway and cell survival', J. Cell. Mol. Med., 2005, 9, p. 59-71
42. Chen, J., Somanath, P.R., and Razorenova, O.: Et al. 'Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo', Nat. Med., 2005, 11, p. 1188-1196
43. Biswas, D.K., and Iglehart, J.D.: 'Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer', J. Cell Physiol., 2006, 209, p. 645-652
44. Zhang, Y., Banerjee, S., and Wang, Z.: Et al. 'Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer', Cancer Res., 2006, 66, p. 1025-1032
45. Hendriks, B.S., Opresko, L.K., Wiley, H.S., and Lauffenburger, D.: 'Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: Quantitative analysis of HER2 overexpression effects', Cancer Res., 2003, 63, p. 1130-1137
46. Shankaran, H., Zhang, Y., Opresko, L., and Resat, H.: 'Quantifying the effects of EGFR-HER2 co-expression on HER activation and trafficking', Biochem. Biophys. Res. Commun., 2008
47. Band, V., and Sager, R.: 'Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types', Proc. Natl Acad. Sci. USA, 1989, 86, p. 1249-1253 0027-8424
48. Schooler, K., and Wiley, H.S.: 'Ratiometric assay of epidermal growth factor receptor tyrosine kinase activation', Anal. Biochem., 2000, 277, p. 135-142
49. Oppenheim, A.V., Willsky, A.S., and Young, I.T.: 'Signals and systems', (Prentice-Hall Inc., Englewood Cliffs, NJ 1983)
50. Jackson, J.G., St Clair, P., Sliwkowski, M.X., and Brattain, M.G.: 'Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects', Cancer Res., 2004, 64, p. 2601-2609
51. Soltoff, S.P., Carraway, K.L., Prigent, S.A., Gullick, W.G., and Cantley, L.C.: 'ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor', Mol. Cell. Biol., 1994, 14, p. 3550-3558
52. Kholodenko, B.N.: 'Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades', Eur. J. Biochem., 2000, 267, p. 1583-1588